gatifloxacin has been researched along with Eye Infections in 5 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Eye Infections: Infection, moderate to severe, caused by bacteria, fungi, or viruses, which occurs either on the external surface of the eye or intraocularly with probable inflammation, visual impairment, or blindness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this retrospective, longitudinal study, the microbiology laboratory records of patients with different ocular infections diagnosed at an eye institute in central India from 2005-2020 were reviewed to determine the pattern of fluoroquinolone (ciprofloxacin, ofloxacin, gatifloxacin, and moxifloxacin) resistance." | 4.12 | Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020. ( Agrawal, D; Chatterjee, S; Gangwe, AB; Gomase, SN; Mishra, M; Parchand, SM, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatterjee, S | 3 |
| Agrawal, D | 3 |
| Gomase, SN | 3 |
| Parchand, SM | 3 |
| Gangwe, AB | 3 |
| Mishra, M | 3 |
| Sy-Ongkeko, JM | 1 |
| Agahan, AL | 1 |
| Lopez, JS | 1 |
| Dy-Liacco, JU | 1 |
| Juárez-Verdayes, MA | 1 |
| Parra-Ortega, B | 1 |
| Hernández-Rodríguez, C | 1 |
| Betanzos-Cabrera, G | 1 |
| Rodríguez-Martínez, S | 1 |
| Cancino-Diaz, ME | 1 |
| Cancino-Diaz, JC | 1 |
| Mah, FS | 1 |
| McLeod, SD | 1 |
2 reviews available for gatifloxacin and Eye Infections
| Article | Year |
|---|---|
Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections.
Topics: Administration, Topical; Aza Compounds; Bacterial Infections; Eye Infections; Fluoroquinolones; Gati | 2004 |
Integrating iquix, vigamox, and zymar in the management of ocular infectious disease.
Topics: Anti-Infective Agents; Drug Therapy, Combination; Eye Infections; Fluoroquinolones; Gatifloxacin; Hu | 2006 |
3 other studies available for gatifloxacin and Eye Infections
| Article | Year |
|---|---|
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020.
Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Colistin; Eye Infections; Fluoroquinolones; Gatifl | 2022 |
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020.
Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Colistin; Eye Infections; Fluoroquinolones; Gatifl | 2022 |
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020.
Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Colistin; Eye Infections; Fluoroquinolones; Gatifl | 2022 |
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020.
Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Colistin; Eye Infections; Fluoroquinolones; Gatifl | 2022 |
Sympathetic ophthalmia in an infected post-scleral buckling eye.
Topics: Adrenal Cortex Hormones; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Atropine; Dexamethas | 2011 |
Identification and expression of nor efflux family genes in Staphylococcus epidermidis that act against gatifloxacin.
Topics: Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Bacterial; Eye Infections; Fluoroquinolones; | 2012 |